The JEV Viral Load Quantitative Test is a specialized diagnostic procedure designed to detect and measure the amount of Japanese Encephalitis Virus (JEV) in a patient's blood. This virus is the cause of Japanese encephalitis, a mosquito-borne viral infection that affects the brain and can lead to severe neurological conditions or even death. Early and accurate detection of the virus is crucial for effective treatment and management of the disease.
The test utilizes advanced molecular techniques to quantify the viral RNA, providing healthcare providers with vital information about the severity of the infection and guiding treatment decisions. It is particularly useful in endemic areas or for individuals who have traveled to regions where the virus is prevalent.
At DNA Labs UAE, this test is available for 1870 AED. The lab is equipped with state-of-the-art technology to ensure high accuracy and reliability of the test results. DNA Labs UAE is known for its commitment to providing quality diagnostic services, making it a trusted choice for patients and healthcare providers seeking JEV Viral Load Quantitative Testing.
The "JAK-2 Mutation Detection RNA Detection Qualitative Test" is a specialized diagnostic procedure aimed at identifying the presence of mutations in the JAK2 gene, which are often associated with certain types of blood cancers, including myeloproliferative neoplasms. This test is qualitative, meaning it is designed to determine whether the mutation is present or not, rather than quantifying the amount of mutated gene.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test involves analyzing the patient's RNA to detect any alterations in the JAK2 gene. The process is critical for diagnosing conditions like polycythemia vera, essential thrombocythemia, and myelofibrosis, enabling healthcare providers to tailor treatment plans more effectively.
The cost of the test is 1870 AED, reflecting the sophisticated technology and expertise required to accurately identify the JAK-2 mutation. This investment can be invaluable for patients needing precise diagnoses for their conditions, facilitating targeted therapies that can significantly improve outcomes.
The Metapneumonia Virus A/B Detection and Differentiation RNA Detection Qualitative Test is a specialized diagnostic procedure designed to identify and distinguish between the Metapneumovirus types A and B. This test employs advanced RNA detection techniques to qualitatively assess the presence of the virus in patient samples. The differentiation between types A and B is crucial for understanding the specific virus strain, which can help in tailoring the most effective treatment plans and managing potential outbreaks. Conducted at DNA Labs UAE, a leading facility in genetic and virological diagnostics, the test ensures high accuracy and reliability. The cost of this comprehensive test is set at 1870 AED, reflecting the sophisticated technology and expertise involved in the detection process. By offering this test, DNA Labs UAE provides a critical tool in the fight against respiratory infections caused by the Metapneumovirus, aiding in the prompt and effective care of affected individuals.
The "Shrimp WSSV, MBV, HPV, IHHNV DNA Virus Multiplex Detection and Differentiation RNA Detection Qualitative Test" is a comprehensive diagnostic assay performed at DNA Labs UAE, designed specifically for the aquaculture industry. This qualitative test simultaneously detects and differentiates between four major shrimp pathogens: White Spot Syndrome Virus (WSSV), Monodon Baculovirus (MBV), Hepatopancreatic Parvovirus (HPV), and Infectious Hypodermal and Hematopoietic Necrosis Virus (IHHNV). These pathogens are responsible for significant economic losses in shrimp farming globally, making early and accurate detection critical for effective disease management and prevention.
The test employs advanced molecular techniques to identify the presence of DNA from these viruses in shrimp samples, ensuring high sensitivity and specificity. By utilizing a multiplex approach, it allows for the simultaneous screening of the four viruses in a single assay, making it a cost-effective and time-saving solution for shrimp farmers and aquaculture health professionals.
The cost of the test is set at 1870 AED, reflecting the sophisticated technology and expertise involved in conducting the assay. Conducted at DNA Labs UAE, a facility known for its state-of-the-art equipment and stringent quality control measures, clients can expect reliable and accurate results that are crucial for the health management of shrimp populations and the sustainability of shrimp farming operations.
The DPD Gene Mutations 5-FU Toxicity Detection Test is a crucial diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the DPD gene. Dihydropyrimidine dehydrogenase (DPD) is an enzyme responsible for the breakdown of 5-fluorouracil (5-FU), a common chemotherapeutic drug used in the treatment of various cancers. Mutations in the DPD gene can lead to decreased activity of this enzyme, resulting in an increased risk of severe or potentially life-threatening toxicity in patients receiving 5-FU-based chemotherapy.
This test is specifically aimed at detecting these genetic variations to help healthcare providers make informed decisions regarding the use of 5-FU in cancer treatment. By identifying individuals with DPD deficiency, the test allows for the adjustment of drug dosages or the consideration of alternative therapies, thereby minimizing the risk of adverse reactions and enhancing patient safety.
Priced at 1870 AED, the test is conducted at DNA Labs UAE, which is equipped with state-of-the-art technology and staffed by experienced professionals to ensure accurate and reliable results. The investment in this test could be invaluable for patients undergoing cancer treatment, as it aids in personalizing therapy plans to optimize outcomes and minimize the risk of toxicity.
The Gastrin Stimulation by Secretin Test is a diagnostic procedure designed to evaluate the function of the stomach and diagnose certain conditions related to the gastrointestinal system, such as Zollinger-Ellison Syndrome, which involves the overproduction of gastrin. During the test, secretin, a hormone that stimulates the secretion of gastric acid, is administered to the patient. The response of gastrin levels in the blood is then measured. This response can provide valuable information about the health and functioning of the stomach and pancreas.
The cost of the Gastrin Stimulation by Secretin Test at DNA Labs UAE is set at 1970 AED. DNA Labs UAE is a reputable facility known for its state-of-the-art equipment and highly qualified staff, ensuring that the test is conducted with the utmost precision and care. This test is particularly useful for healthcare providers in diagnosing and managing conditions associated with abnormal gastrin levels, offering a crucial tool in the realm of gastrointestinal healthcare.
The Immunoglobulin IgD and IgE Typing Urine Test is a specialized diagnostic assessment performed to measure the levels of IgD and IgE antibodies in the urine. These immunoglobulins play crucial roles in the body's immune response. IgD is less understood but is believed to be involved in the activation of B cells, while IgE is primarily associated with allergic reactions and the defense against parasitic infections. Elevated levels of these antibodies can indicate various health conditions, including allergies, autoimmune diseases, and certain types of infections.
This test is particularly useful for individuals experiencing symptoms that suggest an allergic reaction, immune system disorders, or for those with a family history of such conditions. It can provide valuable information for the diagnosis and management of related diseases.
The test is conducted at DNA Labs UAE, a reputable facility known for its advanced diagnostic services. The cost of the Immunoglobulin IgD and IgE Typing Urine Test is 1970 AED. Patients are advised to consult with their healthcare provider for proper interpretation of the test results and to discuss the best course of action based on the findings.
The Methylguanine Methyltransferase (MGMT) test is a specialized diagnostic procedure performed to assess the methylation status of the MGMT gene promoter in tumor cells, particularly in glioblastoma, a type of brain tumor. Methylation of the MGMT gene promoter can inhibit the gene's expression, impacting the effectiveness of certain chemotherapy agents. By evaluating the MGMT methylation status, healthcare professionals can tailor cancer treatment plans more effectively, potentially enhancing the therapeutic outcomes for patients.
This test holds significant value in the field of oncology, guiding decisions regarding the use of alkylating agents in chemotherapy regimens. It is particularly crucial for patients with certain types of brain tumors, where treatment customization can lead to improved survival rates and quality of life.
In the United Arab Emirates, this test is available at DNA Labs UAE, a reputable facility known for its advanced diagnostic services. The cost of the MGMT test at DNA Labs UAE is set at 1970 AED. Given the complexity and the specialized nature of this test, it represents a critical investment in the precision medicine approach to cancer treatment, offering hope for more effective and personalized therapy plans for patients facing challenging diagnoses.
The MICM Maternally Inherited Cardiomyopathy Mutation Detection Test is a specialized genetic screening designed to identify mutations associated with maternally inherited cardiomyopathies. This advanced diagnostic tool is crucial for detecting genetic markers that indicate a predisposition to various forms of heart muscle disorders, which are passed down from mother to child. Conducted at DNA Labs UAE, a leading facility in genetic testing, this test offers individuals the opportunity to understand their genetic risk for developing cardiomyopathies, enabling early intervention and personalized management strategies.
Priced at 1970 AED, the test is accessible for those who are looking to take proactive steps in managing their heart health, especially if they have a family history of cardiomyopathy or related heart conditions. By analyzing specific DNA segments, the test can pinpoint mutations that contribute to the development of these heart disorders, providing invaluable information for patients and their healthcare providers. This information not only aids in the early detection and treatment of cardiomyopathy but also helps in the guidance of family planning decisions for those who may carry the genetic markers.
The MMC Maternal Myopathy with Cardiomyopathy Mutation Detection Test is a specialized diagnostic tool offered by DNA Labs UAE, aimed at identifying specific genetic mutations associated with maternal myopathy and cardiomyopathy. This test plays a crucial role in the early detection and management of these conditions, which can have significant implications for maternal health during pregnancy and the postpartum period. Myopathies are disorders affecting muscle function, and cardiomyopathies involve the deterioration of the heart muscle, potentially leading to heart failure. The detection of relevant mutations through this test allows for personalized medical advice, interventions, and monitoring to mitigate health risks for both the mother and the child.
Priced at 1970 AED, the test is conducted in a state-of-the-art laboratory setting by DNA Labs UAE, ensuring high standards of accuracy and reliability. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for genetic markers associated with maternal myopathy and cardiomyopathy. Results from this test can provide essential insights into the patient's genetic predisposition to these conditions, facilitating informed decisions regarding pregnancy planning, healthcare, and lifestyle adjustments to support optimal maternal and fetal outcomes.
